d-alpha tocopherol has been researched along with acyclovir in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| De Luca, C; Kharaeva, Z; Korkina, L; Luci, A; Pastore, P; Raskovic, D | 1 |
| Deriabin, PG; Galegov, GA; Vasil'ev, AN | 1 |
| Cholkar, K; Mitra, AK; Vadlapatla, RK; Vadlapudi, AD | 1 |
| Abd-Elsalam, WH; Ibrahim, RR | 1 |
1 review(s) available for d-alpha tocopherol and acyclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for d-alpha tocopherol and acyclovir
| Article | Year |
|---|---|
Coenzyme Q(10), vitamin E, selenium, and methionine in the treatment of chronic recurrent viral mucocutaneous infections.
Topics: Acyclovir; Administration, Oral; Adult; alpha-Tocopherol; Alphapapillomavirus; Antioxidants; Antiviral Agents; Chronic Disease; Cryotherapy; Dietary Supplements; DNA Virus Infections; DNA, Viral; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Herpes Genitalis; Herpes Zoster; Host-Pathogen Interactions; Humans; Male; Methionine; Middle Aged; Reactive Nitrogen Species; Reactive Oxygen Species; Recurrence; Selenium; Skin Diseases, Infectious; Ubiquinone; Viral Load; Vitamin E; Young Adult | 2012 |
4 other study(ies) available for d-alpha tocopherol and acyclovir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Antiviral activity of recombinant interferon-alpha-2b in combination with certain antioxidant].
Topics: Acyclovir; alpha-Tocopherol; Animals; Antioxidants; Antiviral Agents; Ascorbic Acid; Cell Line; Chlorocebus aethiops; Drug Synergism; Herpes Simplex; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Interferon alpha-2; Interferon-alpha; Kidney; Lung; Recombinant Proteins; Simplexvirus; Swine; Taurine; Unithiol; Vero Cells | 2011 |
Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
Topics: Acyclovir; Administration, Ophthalmic; Antiviral Agents; Biotinylation; Cytokines; Drug Delivery Systems; Epithelium, Corneal; Gene Expression Regulation; Humans; Keratitis, Herpetic; Lipids; Micelles; Nanoparticles; Octoxynol; Particle Size; Polyethylene Glycols; Prodrugs; Real-Time Polymerase Chain Reaction; Surface-Active Agents; Vitamin E | 2014 |
Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections.
Topics: Acyclovir; Chitosan; Drug Carriers; Drug Delivery Systems; Hexoses; Lipids; Nanoparticles; Particle Size; Vitamin E | 2021 |